About Dr Ross Tomlinson
Dr Ross Tomlinson is a clinical haematologist at Icon Cancer Care Centre. He is experienced in caring for a wide range of malignant and non-malignant blood disorders including lymphoma, leukaemia, mul ...
Please verify your email address to receive email notifications.
Enter your email address
We have sent you a verification email. Please check your inbox and spam folder.
Unable to send verification, please refresh and try again later.
Dr Ross Tomlinson is a clinical haematologist at Icon Cancer Care Centre. He is experienced in caring for a wide range of malignant and non-malignant blood disorders including lymphoma, leukaemia, mul ...
Bortezomib use and outcomes for the treatment of multiple myeloma. C. Loke, P. Mollee, I. McPherson, E. Walpole, M. Yue, H. Mutsando, P. Wong, H. Weston, R. Tomlinson & S. Hollingworth. Journal of Internal Medicine, 2020; 50(9): 1059-1066.
Validation of the Boston University staging system in AL amyloidosis. R. Tomlinson, N. Matigian & P. Mollee. Amyloid, 2019; 26(3): 125-127.
Thrombotic thrombocytopenic purpura associated with Hodgkin lymphoma and non-Hodgkin lymphoma. Tomlinson & J. Yaxley. Pathology, 2018; 50(7): 776-777.
Multiple myeloma: updated approach to management 2018. R. Tomlinson. Australian Journal of General Practice, 2018; 47(8): 526-529.
Chronic lymphocytic leukaemia: an updated approach to diagnosis and management in general practice. Australian Family Physician, 2017; 46(7): 493-496.
Your treatment costs may be reduced when the practitioner participates in a health fund member arrangement.
AHPRA: MED0001783392
Australian Medical Association (AMA)
American Society of Haematology (ASH)
Australasian Leukaemia and Lymphoma Group (ALLG)
Haematology Society of Australia and New Zealand (HSANZ)
Royal Australasian College of Physicians (RACP)
Royal College of Pathologists of Australasia (RCPA)